These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14906847)

  • 1. Failure to influence the blood coagulation time by sublingual administration of heparin.
    KENNEDY AC; BROWN A
    Glasgow Med J; 1952 Mar; 33(3):89-91. PubMed ID: 14906847
    [No Abstract]   [Full Text] [Related]  

  • 2. [A heparin preparation with prolonged effect, heparin prolongatum for intramuscular injection; preliminary report].
    DOLLERUP E; HEIGAARD JJ; HOLTEN C
    Ugeskr Laeger; 1955 Oct; 117(42):1379-81. PubMed ID: 13281957
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on: The relationship between heparin level and activated clotting time in the adult cardiac surgery population.
    Fitzgerald D
    Perfusion; 2009 Mar; 24(2):97. PubMed ID: 19654151
    [No Abstract]   [Full Text] [Related]  

  • 5. Low heparinization and heparin-bonded circuits.
    Hill RC
    Ann Thorac Surg; 1997 Oct; 64(4):1221-2. PubMed ID: 9354574
    [No Abstract]   [Full Text] [Related]  

  • 6. [Administration and duration of effect of a new type of heparin, Vister heparin].
    MALAGAMBA G
    Quad Clin Ostet Ginecol; 1952 Nov; 7(11):703-8. PubMed ID: 13047550
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant kinetics following bolus injection of heparin.
    Mockros LF; Hirsch SD; Zuckerman L; Caprini JA; Robinson WP; Vagher JP
    Thromb Haemost; 1979 Dec; 42(4):1248-60. PubMed ID: 542932
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):121-8. PubMed ID: 7468138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When we "act" on ACT levels: activated clotting time measurements to guide heparin administration during and after interventional procedures.
    Klein LW; Agarwal JB
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):154-7. PubMed ID: 8808071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Mar; 85(3):346-53. PubMed ID: 6827843
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring of blood coagulation in open heart surgery. I. Effects of conventional dosages of heparin and protamine.
    Dercksen SJ; Linssen GH
    Acta Anaesthesiol Belg; 1980; 31(2):113-9. PubMed ID: 7468137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous activated clotting time after intra-arterial heparin: effect of site of administration and timing of sampling.
    Kerensky RA; Azar GJ; Bertolet B; Hill JA; Kutcher MA
    Cathet Cardiovasc Diagn; 1996 Feb; 37(2):151-3. PubMed ID: 8808070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of suboptimal concentrations of sodium citrate upon the clotting times of human and dog blood after intravenous administration of heparin.
    LOSNER S; VOLK BW
    Am J Med Sci; 1952 Dec; 224(6):673-8. PubMed ID: 12996513
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Routine heparinization and activated clotting time (ACT) in patients operated on under extracorporeal circulation].
    Kalawski R; Krzyś T; Leciej M
    Wiad Lek; 1982 Oct; 35(18):1119-24. PubMed ID: 7179984
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does dabigatran interfere with intraablation heparinization?
    Sairaku A; Nakano Y; Kihara Y
    Thromb Res; 2014 Sep; 134(3):742-3. PubMed ID: 25034323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.